Traditional Stimulants vs Other Wake-Promoting Agents

Slides:

Advertisements

Similar presentations

Narcolepsy Senior Project Power Point Presented By : Ziera M. High

Advertisements

Sleep When a cup of warm milk is not enough K. Van Gundy, M.D. Associate Clinical Professor UCSF.

Yovany Gaspar Psychology Period 5. A sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. The brain’s inability to control.

Sleep and Safety Emphasis on DOT guidelines Christopher M Nolte, MD, MS Comprehensive Sleep Wellness Center Knoxville, TN.

Sleep Disorders Basics of Sleep Basics of Sleep  Stages  REM and NREM Sleep.

Overview Narcolepsy Project By Jessie Y. Shen Wednesday, Oct. 15, 2003.

By Minh Tran Narcolepsy. What is Narcolepsy? Narcolepsy is a neurologic disorder characterized by excessive daytime sleepiness and abnormal REM sleep.

Narcolepsy By: Emeline Vinkenes and Sunniva Kruse Johannesen.

BY STEPHANIE SALAZAR Narcolepsy. What is Narcolepsy? Narcolepsy is a sleep disorder, causing excessive sleepiness and frequent daytime sleep attacks.

Sleep case #1. Case 64 yo male smoker with hyperlipidemia BMI 28 Prev diagnosis of OSA Referred for daytime sleepiness.

Neurological Disorder NARCOLEPSY. What is it? Chronic neurological disorder affecting brain’s ability to regulate sleep-wake cycles. Two types: Narcolepsy.

By Minh Tran Narcolepsy. What is Narcolepsy? Narcolepsy is a neurologic disorder characterized by excessive daytime sleepiness and abnormal REM sleep.

Multimodal Management of Opioid-Induced Constipation

Applying the New Multiple Sclerosis Guidelines to Clinical Practice

The Nurse View: Management of Pancreatic Cancer

Challenges and Opportunities in the Management of ANCA-Associated Vasculitis.

Pharmacy Perspectives in Multiple Myeloma: Relapsed and/or Refractory Disease.

Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.

Perspectives on Triple-Negative Breast Cancer

Starting Strong: Initial Evaluation of the Patient With HCV

Exploring the Spectrum of Excessive Daytime Sleepiness

Goals of Therapy for Patients With UC

Thrombosis, Cancer, and NOACs

Expert Perspectives on Clinically Challenging Cases in Narcolepsy

Progression After Cancer Immunotherapy in Advanced NSCLC

Addressing Neuropsychiatric Symptoms in Patients With Dementia

Beyond the Basics: What You Need to Know About Treating Insomnia

Complicated Cases in Ulcerative Colitis

Diagnosis and Management of Narcolepsy in Psychiatry:

Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.

IL-17 Inhibitors in the Management of Psoriatic Disease

Improving Narcolepsy Diagnosis

Precision Management of RA and Comorbidities

Seizures in the Elderly: Treatment and Special Considerations

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.

From Symptom Management to Communication in Advanced GI Cancers

Improving Outcomes in OSA

Management of Adolescents With Seizures

Forming Effective Individualized Treatment Plans for Patients With Low-Risk MDS.

EHL Technologies in Hemophilia Care

Program Goals Disclaimer Overview Assessing Disease Activity.

Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors

Program Goals Overview Glatiramer Acetate 3 Times a Week.

Charting Progress in MS Treatment:

Over-the-Counter Allergic Rhinitis Treatments

ADVANCED PARKINSON'S DISEASE:

Advancing the Treatment of IBD With Biologics

When Is Biologic Therapy Appropriate for HS?

Managing Polycythemia Vera in the Community Setting

Program Overview. Major Depressive Disorder: The Challenging Patient and the Goal of Recovery.

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

Cancer-Associated Thrombosis

Viewpoints of Practicing Rheumatologists: Case Discussions in RA

New Approaches to Insomnia Management: Impact on Clinical Practice

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.

Considerations for Managing Insomnia in Older Adults

Patient-Centered Management in Advanced Non-Small Cell Lung Cancer

Critical Decision Points in Insomnia

Application of Biologics in IBD:

Incorporating Prostacyclins Into Practice

Treating Atypical Hemolytic Uremic Syndrome A Case Discussion

Clinical Challenges and Updates in Managing Seizure Clusters

An Appraisal of Narcolepsy Guidelines

What You Need To Know To Effectively Manage Patients With MDD Key Terms (cont)

Program Goals Overview Is NEDA a Reasonable Target?

NOACs and Reversal Agents

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

Issues in Patients With Severe Epilepsy

AMD Therapy: Where Are We Now and Where Are We Going?

Rational Pharmacotherapy Selection for Insomnia

Presentation transcript:

Traditional Stimulants vs Other Wake-Promoting Agents

Program Goals

Narcolepsy Treatment Goals

General Approach to Narcolepsy Management For All Patients

Sleep Hygiene

Case Excessive Sleepiness and Feeling “Down”

Initial Treatment Patient- and Disease-Related Considerations

Treating EDS AASM Practice Parameters for Narcolepsy (2007)

Traditional Stimulants Sympathomimetic Agents

Traditional Stimulants Adverse Effects

Other Wake-Promoting Agents Modafinil/Armodafinil

Treatment of Cataplexy and Ancillary Symptoms AASM Practice Parameters for Narcolepsy (2007)

Treatment of Cataplexy and Ancillary Symptoms Antidepressants

Sodium Oxybate

Sodium Oxybate Precautions and Limitations

Case: Treatment Plan (cont) Factors to Consider

Summary Key Messages

Abbreviations